Theratechnologies Inc. Net Assets

Latest as of May 2025: CA$-27.92 Million CAD ≈ $-20.20 Million USD

Theratechnologies Inc. net assets. Based on the latest financial reports, Theratechnologies Inc. (TH) has net assets worth CA$-27.92 Million CAD (≈ $-20.20 Million USD) as of May 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$51.27 Million ≈ $37.09 Million USD) and total liabilities (CA$79.19 Million ≈ $57.29 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore TH net assets growth trend to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CA$-27.92 Million
% of Total Assets	-54.46%
Annual Growth Rate	N/A
5-Year Change	-883.87%
10-Year Change	-268.75%
Growth Volatility	111.06

Net Assets of Theratechnologies Inc. (1996–2024)

Net assets of Theratechnologies Inc. from 1996 to 2024. This chart illustrates how Theratechnologies Inc.'s net assets have evolved over time, based on quarterly financial data. See TH net asset quality index to measure how much of total assets are equity-financed.

Annual Net Assets for Theratechnologies Inc. (1996–2024)

The table below shows the annual net assets of Theratechnologies Inc. from 1996 to 2024. For live market cap and overall valuation, see Theratechnologies Inc. market cap and net worth.

Year	Net Assets	Change
2024-11-30	CA$-25.27 Million ≈ $-18.28 Million	-21.09%
2023-11-30	CA$-20.87 Million ≈ $-15.10 Million	+7.54%
2022-11-30	CA$-22.57 Million ≈ $-16.33 Million	-227.09%
2021-11-30	CA$17.76 Million ≈ $12.85 Million	+450.87%
2020-11-30	CA$3.22 Million ≈ $2.33 Million	-87.02%
2019-11-30	CA$24.83 Million ≈ $17.96 Million	-29.16%
2018-11-30	CA$35.05 Million ≈ $25.36 Million	+4.61%
2017-11-30	CA$33.51 Million ≈ $24.24 Million	+67.42%
2016-11-30	CA$20.02 Million ≈ $14.48 Million	+33.65%
2015-11-30	CA$14.98 Million ≈ $10.83 Million	+118.02%
2014-11-30	CA$6.87 Million ≈ $4.97 Million	-60.64%
2013-11-30	CA$17.45 Million ≈ $12.62 Million	-23.53%
2012-11-30	CA$22.82 Million ≈ $16.51 Million	-35.16%
2011-11-30	CA$35.20 Million ≈ $25.46 Million	-31.85%
2010-11-30	CA$51.65 Million ≈ $37.36 Million	+26.90%
2009-11-30	CA$40.70 Million ≈ $29.44 Million	+7.67%
2008-11-30	CA$37.80 Million ≈ $27.35 Million	-42.68%
2007-11-30	CA$65.94 Million ≈ $47.70 Million	+69.25%
2006-11-30	CA$38.96 Million ≈ $28.18 Million	-7.14%
2005-11-30	CA$41.96 Million ≈ $30.35 Million	-20.86%
2004-11-30	CA$53.02 Million ≈ $38.35 Million	-17.78%
2003-11-30	CA$64.48 Million ≈ $46.65 Million	-18.90%
2002-11-30	CA$79.51 Million ≈ $57.52 Million	+12.07%
2001-11-30	CA$70.95 Million ≈ $51.32 Million	+84.12%
2000-11-30	CA$38.53 Million ≈ $27.87 Million	+127.88%
1999-11-30	CA$16.91 Million ≈ $12.23 Million	+54.60%
1998-11-30	CA$10.94 Million ≈ $7.91 Million	+55.64%
1997-11-30	CA$7.03 Million ≈ $5.08 Million	-40.44%
1996-11-30	CA$11.80 Million ≈ $8.54 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Theratechnologies Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 40508737106.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Theratechnologies Inc. Net Assets Breakdown (November 2024)

Theratechnologies Inc. net assets breakdown by equity component as of November 2024.

Component	Amount	Percentage
Common Stock	CA$363.93 Million	%
Other Components	CA$27.69 Million	%
Total Equity	CA$-25.27 Million	100.00%

Theratechnologies Inc. Competitors by Market Cap

The table below lists competitors of Theratechnologies Inc. ranked by their market capitalization.

Company	Market Cap
Sonmez Filament Sentetik Iplik ve Elyaf Sanayi AS IS:SONME	$148.75 Million
Tofu Restaurant Co Ltd TWO:2752	$148.86 Million
Chaman Lal Setia Exports Limited NSE:CLSEL	$148.88 Million
Mayne Pharma Group Ltd AU:MYX	$148.89 Million
Capral Ltd AU:CAA	$148.59 Million
Univacco Technology TWO:3303	$148.53 Million
Gemini Space Station, Inc. Class A Common Stock NASDAQ:GEMI	$148.31 Million
UniTest Incorporation KQ:086390	$148.27 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Theratechnologies Inc.'s equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from -20,870,000 to -25,272,000, a change of -4,402,000.
Net loss of 8,306,000 reduced equity.
Other comprehensive income decreased equity by 683,999.
Other factors increased equity by 4,587,999.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	CA$-8.31 Million	-32.87%
Other Comprehensive Income	CA$-684.00K	-2.71%
Other Changes	CA$4.59 Million	+18.15%
Total Change	CA$-	%

Book Value vs Market Value Analysis

This analysis compares Theratechnologies Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
1996-11-30	CA$0.80	CA$4.47	x
1997-11-30	CA$0.42	CA$4.47	x
1998-11-30	CA$0.60	CA$4.47	x
1999-11-30	CA$0.83	CA$4.47	x
2000-11-30	CA$1.43	CA$4.47	x
2001-11-30	CA$1.97	CA$4.47	x
2002-11-30	CA$2.15	CA$4.47	x
2003-11-30	CA$1.76	CA$4.47	x
2004-11-30	CA$1.49	CA$4.47	x
2005-11-30	CA$1.17	CA$4.47	x
2006-11-30	CA$0.90	CA$4.47	x
2007-11-30	CA$1.25	CA$4.47	x
2008-11-30	CA$0.66	CA$4.47	x
2009-11-30	CA$0.67	CA$4.47	x
2010-11-30	CA$0.84	CA$4.47	x
2011-11-30	CA$0.58	CA$4.47	x
2012-11-30	CA$0.37	CA$4.47	x
2013-11-30	CA$0.29	CA$4.47	x
2014-11-30	CA$0.11	CA$4.47	x
2015-11-30	CA$0.24	CA$4.47	x
2016-11-30	CA$0.30	CA$4.47	x
2017-11-30	CA$0.46	CA$4.47	x
2018-11-30	CA$0.46	CA$4.47	x
2019-11-30	CA$0.32	CA$4.47	x
2020-11-30	CA$0.04	CA$4.47	x
2021-11-30	CA$0.19	CA$4.47	x
2022-11-30	CA$-0.24	CA$4.47	x
2023-11-30	CA$-0.79	CA$4.47	x
2024-11-30	CA$-0.55	CA$4.47	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Theratechnologies Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 0.00%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -9.67%
• Asset Turnover: 1.61x
• Equity Multiplier: 0.00x
Recent ROE (0.00%) is above the historical average (-59.47%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
1996	-29.56%	-940.00%	0.02x	1.38x	CA$-4.67 Million
1997	-57.00%	-1425.00%	0.03x	1.21x	CA$-4.71 Million
1998	-30.36%	-463.64%	0.06x	1.14x	CA$-4.41 Million
1999	-19.68%	-326.67%	0.06x	1.09x	CA$-5.02 Million
2000	9.79%	470.29%	0.01x	1.43x	CA$-79.46K
2001	30.31%	593.71%	0.03x	1.61x	CA$11.38 Million
2002	-13.97%	-167.26%	0.06x	1.37x	CA$-15.72 Million
2003	-46.53%	-818.02%	0.04x	1.34x	CA$-30.67 Million
2004	-36.24%	-861.31%	0.04x	1.08x	CA$-24.52 Million
2005	-29.27%	-87.13%	0.31x	1.09x	CA$-16.48 Million
2006	-58.15%	-1568.28%	0.03x	1.15x	CA$-26.55 Million
2007	-56.97%	-1199.36%	0.04x	1.13x	CA$-44.16 Million
2008	-104.28%	-1853.58%	0.05x	1.15x	CA$-43.20 Million
2009	-34.98%	-86.20%	0.25x	1.61x	CA$-18.31 Million
2010	16.96%	28.02%	0.44x	1.36x	CA$3.59 Million
2011	-48.79%	-118.77%	0.28x	1.45x	CA$-20.69 Million
2012	-61.49%	-102.75%	0.37x	1.60x	CA$-16.32 Million
2013	-21.89%	-53.69%	0.30x	1.34x	CA$-5.56 Million
2014	-133.97%	-156.58%	0.21x	4.15x	CA$-9.89 Million
2015	7.85%	5.23%	0.60x	2.50x	CA$-322.64K
2016	1.52%	1.11%	0.70x	1.97x	CA$-1.70 Million
2017	-42.79%	-43.04%	0.56x	1.77x	CA$-17.69 Million
2018	-12.92%	-10.27%	0.40x	3.17x	CA$-8.03 Million
2019	-70.41%	-27.66%	0.54x	4.73x	CA$-19.97 Million
2020	-703.07%	-34.32%	0.66x	31.06x	CA$-22.99 Million
2021	-178.63%	-45.44%	0.59x	6.71x	CA$-33.50 Million
2022	0.00%	-59.00%	0.86x	0.00x	CA$-44.98 Million
2023	0.00%	-29.30%	1.05x	0.00x	CA$-21.87 Million
2024	0.00%	-9.67%	1.61x	0.00x	CA$-5.78 Million

Industry Comparison

This section compares Theratechnologies Inc.'s net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $15,150,773
Average return on equity (ROE) among peers: -5.58%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Theratechnologies Inc. (TH)	CA$-27.92 Million	-29.56%	N/A	$148.68 Million
Appili Therapeutics Inc (APLI)	$-10.92 Million	0.00%	0.00x	$464.29K
Aptose Biosciences Inc (APS)	$118.92 Million	-46.45%	0.06x	$4.43 Million
Arch Biopartners Inc (ARCH)	$-3.88 Million	0.00%	0.00x	$43.24 Million
Biomind Labs Inc (BMND)	$-1.43 Million	0.00%	0.00x	$19.92 Million
Cybin Inc (CYBN)	$1.45 Million	0.00%	0.18x	$301.37 Million
Eastwood Bio-Medical Canada Inc (EBM)	$1.31 Million	-44.19%	0.26x	$89.55 Million
Eupraxia Pharmaceuticals Inc (EPRX)	$45.77 Million	-76.33%	0.10x	$353.56 Million
Devonian Health Group Inc (GSD)	$5.19 Million	111.16%	1.26x	$12.57 Million
Helix BioPharma Corp. (HBP)	$-844.00K	0.00%	0.00x	$50.83 Million
Hemostemix Inc (HEM)	$-4.05 Million	0.00%	0.00x	$6.82 Million

About Theratechnologies Inc.

TO:TH Canada Biotechnology

Market Cap

$148.68 Million

CA$205.53 Million CAD

Market Cap Rank

#17493 Global

#551 in Canada

Share Price

CA$4.47

Change (1 day)

+0.00%

52-Week Range

CA$4.47 - CA$4.47

All Time High

CA$58.28